Yano, W., Inoue, N., Ito, S., Itou, T., Yasumura, M., Yoshinaka, Y., . . . Kaku, K. (2016). Mechanism of lipid‐lowering action of the dipeptidyl peptidase‐4 inhibitor, anagliptin, in low‐density lipoprotein receptor‐deficient mice. J Diabetes Investig.
Chicago ZitierstilYano, Wataru, et al. "Mechanism of Lipid‐lowering Action of the Dipeptidyl Peptidase‐4 Inhibitor, Anagliptin, in Low‐density Lipoprotein Receptor‐deficient Mice." J Diabetes Investig 2016.
MLA ZitierstilYano, Wataru, et al. "Mechanism of Lipid‐lowering Action of the Dipeptidyl Peptidase‐4 Inhibitor, Anagliptin, in Low‐density Lipoprotein Receptor‐deficient Mice." J Diabetes Investig 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.